Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry
The SSRN website posted an article which noted that the pharmaceutical industry extensively relies on the patent system. It actively lobbies for the strengthening of the patent protection of its medical products. The results of its efforts may be found in bilateral and multilateral agreements. However, some recent developments reflect the emerging tendency
Comments Off on Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry • Read this story »
More Articles
How to Connect IP Management to Open Innovation
The Garwood Center for Corporate Innovation posted an article which noted that in the earliest phase of the technology lifecycle, it pays to be very open. As the dominant design emerges, tightening the protection for one’s ideas becomes very important. Managing internal and external innovations and
Comments Off on How to Connect IP Management to Open Innovation • Read this story »
How to Connect IP Management to Open Innovation
A blog on the Garfield Center for Corporate Innovation website noted that in the earliest phase of the technology lifecycle, it pays to be very open. Neither you nor others know yet the best use of a particular technology, and no one has an appropriate business model to commercialize any applications
Comments Off on How to Connect IP Management to Open Innovation • Read this story »